Both in Pharmaceuticals
Mineralys Therapeutics vs Bausch Health Companies
Over the past year MLYS returned −37.8% and BHC returned −10.4%; their daily moves had a correlation of 0.12.
MLYS −37.8% BHC −10.4%Growth of $1, one year, split-adjusted
| Metric | MLYS | BHC |
|---|---|---|
| Price | $24.48 | $5.80 |
| Market cap | $2.16B | $2.17B |
| Today | −4.49% | +0.52% |
| 1 month | −4.4% | −8.2% |
| 6 months | +4.1% | +15.3% |
| Year to date | −32.5% | −16.5% |
| 1 year | −38.8% | −10.5% |
| Revenue growth (YoY) | — | +12.7% |
| Gross margin | — | 72.9% |
| Net margin | — | 9.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $563.8M | -$18.94B |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 72.8% |
| Short % of float | 15.9% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).